针对质母细胞瘤中的代谢重编程作为克服治疗耐药性的新策略
Simona D'Aprile1, Simona Denaro1, Anna Gervasi1
1Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Frontiers in cell and developmental biology
|March 13, 2025
概括
质母细胞瘤 (GBM) 利用代谢重编程来促进生长和治疗耐药性. 准这些代谢途径为这种侵略性脑瘤提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 神经瘤学神经瘤学
背景情况:
- 质母细胞瘤 (GBM) 是一种高度侵略性的脑瘤,患者的治疗结果不佳.
- GBM表现出显著的代谢重编程,包括华堡效应,以促进扩散.
- 代谢重新连接有助于抵抗放射治疗和化疗.
研究的目的:
- 审查GBM代谢重编程的关键机制.
- 探索新陈代谢变化在治疗耐药性的作用.
- 突出GBM治疗的潜在代谢标.
主要方法:
- 关于GBM代谢和治疗耐药性的研究的文献综述.
- 对参与GBM生长和生存的代谢途径的分析.
- 对GBM新兴代谢疗法的评估.
主要成果:
- 代谢重编程为GBM细胞增殖提供必要的代谢物.
- 改变的核酸,脂质和铁代谢有助于瘤生长和治疗抵抗.
- GBM的异质性导致了各个亚型的多样化代谢特征.
结论:
- 代谢重编程是GBM的关键标志,既有利于瘤,又可能是治疗的弱点.
- 针对GBM新陈代谢,结合标准治疗,显示在敏感化瘤的承诺.
- 了解特定亚型的代谢变化对于开发有效的个性化GBM疗法至关重要.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...